Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03128723 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

A NA study of Acne Vulgaris, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT03128723 is a NA study of Acne Vulgaris that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 45 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03128723, a NA study of Acne Vulgaris, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The study will look to evaluate the tolerance of a light therapy-based acne mask device in participants who report having sensitive skin. All participants will receive a cleanser, a light therapy mask, and an extra activator for the light therapy mask.

Conditions Studied

Interventions

  • DEVICE Acne Mask

Study Locations (1)

Tennessee

  • Tennessee Clinical Research Center - Nashville

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2017-04-30
Est. Completion 2017-06-08
Phase NA

What the Registry Record Tells You About NCT03128723

The ClinicalTrials.gov registry entry for NCT03128723 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (84% lower). The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Acne Mask is the first listed.

NCT03128723 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03128723 about?

NCT03128723 is a clinical study titled "A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris". The study will look to evaluate the tolerance of a light therapy-based acne mask device in participants who report having sensitive skin. All participants will receive a cleanser, a light therapy mask, and an extra activator for the light therapy mask.

What is the current status of trial NCT03128723?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-04-30. Estimated completion is 2017-06-08.

What conditions does trial NCT03128723 study?

This clinical trial studies the following conditions: Acne Vulgaris.

What interventions are being tested in trial NCT03128723?

The interventions under investigation include: Acne Mask (DEVICE).

Who is sponsoring clinical trial NCT03128723?

This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03128723 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne Vulgaris

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.